These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10415424)

  • 21. Pharmacological characterization of orphanin FQ/nociceptin and its fragments.
    Rossi GC; Leventhal L; Bolan E; Pasternak GW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):858-65. PubMed ID: 9262352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic intracerebroventricular infusion of nociceptin/orphanin FQ produces body weight gain by affecting both feeding and energy metabolism in mice.
    Matsushita H; Ishihara A; Mashiko S; Tanaka T; Kanno T; Iwaasa H; Ohta H; Kanatani A
    Endocrinology; 2009 Jun; 150(6):2668-73. PubMed ID: 19196798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose Nociceptin/Orphanin FQ reduces anxiety-like performance in alcohol-withdrawn, but not alcohol-naïve, Male Wistar rats.
    Aujla H; Nedjadrasul D
    Neuropharmacology; 2015 Jun; 93():1-6. PubMed ID: 25617519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of orphanin FQ on endomorphin-1 induced analgesia.
    Wang YQ; Zhu CB; Wu GC; Cao XD; Wang Y; Cui DF
    Brain Res; 1999 Jul; 835(2):241-6. PubMed ID: 10415379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of orphanin FQ on acupuncture analgesia and noxious stimulation in the periaqueductal gray].
    Wang H; Zhu CB; Cao XD; Wu GC
    Sheng Li Xue Bao; 1998 Jun; 50(3):263-7. PubMed ID: 11324565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A model of 'antipredator' defense in Swiss-Webster mice: effects of benzodiazepine receptor ligands with different intrinsic activities.
    Griebel G; Blanchard DC; Jung A; Blanchard RJ
    Behav Pharmacol; 1995 Nov; 6(7):732-745. PubMed ID: 11224376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mouse defense test battery: evaluation of the effects of non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands.
    Griebel G; Sanger DJ; Perrault G
    Behav Pharmacol; 1996 Nov; 7(6):560-572. PubMed ID: 11224453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The orphanin FQ/nociceptin (OFQ/N) system.
    Civelli O
    Results Probl Cell Differ; 2008; 46():1-25. PubMed ID: 18193175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intrathecal nocistatin on nociceptin/orphanin FQ analgesia in chronic constriction injury rat.
    Ma F; Xie H; Dong ZQ; Wang YQ; Wu GC
    Brain Res; 2003 Oct; 988(1-2):189-92. PubMed ID: 14519541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous orphanin FQ: evidence for a role in the modulation of electroacupuncture analgesia and the development of tolerance to analgesia produced by morphine and electroacupuncture.
    Tian JH; Zhang W; Fang Y; Xu W; Grandy DK; Han JS
    Br J Pharmacol; 1998 May; 124(1):21-6. PubMed ID: 9630338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens.
    Zhang G; Murray TF; Grandy DK
    Brain Res; 1997 Oct; 772(1-2):102-6. PubMed ID: 9406961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that the behaviors in the Mouse Defense Test Battery relate to different emotional states: a factor analytic study.
    Griebel G; Blanchard DC; Blanchard RJ
    Physiol Behav; 1996 Nov; 60(5):1255-60. PubMed ID: 8916179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam.
    Griebel G; Blanchard DC; Jung A; Lee JC; Masuda CK; Blanchard RJ
    Neuropharmacology; 1995 Dec; 34(12):1625-33. PubMed ID: 8788960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orphanin FQ stimulates prolactin and growth hormone release in male and female rats.
    Bryant W; Janik J; Baumann M; Callahan P
    Brain Res; 1998 Oct; 807(1-2):228-33. PubMed ID: 9757048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms.
    Yu TP; Xie CW
    J Neurophysiol; 1998 Sep; 80(3):1277-84. PubMed ID: 9744938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation.
    Green MK; Barbieri EV; Brown BD; Chen KW; Devine DP
    Neuropeptides; 2007 Dec; 41(6):399-410. PubMed ID: 17980908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocaine potentiates defensive behaviors related to fear and anxiety.
    Blanchard DC; Blanchard RJ
    Neurosci Biobehav Rev; 1999 Nov; 23(7):981-91. PubMed ID: 10580312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cocaine produces panic-like flight responses in mice in the mouse defense test battery.
    Blanchard RJ; Kaawaloa JN; Hebert MA; Blanchard DC
    Pharmacol Biochem Behav; 1999 Nov; 64(3):523-8. PubMed ID: 10548266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defensive behaviors in wild and laboratory (Swiss) mice: the mouse defense test battery.
    Blanchard RJ; Hebert MA; Ferrari PF; Palanza P; Figueira R; Blanchard DC; Parmigiani S
    Physiol Behav; 1998 Nov; 65(2):201-9. PubMed ID: 9855467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.